Does Hazelnut Blood Lipids Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Hazelnut Blood Lipids Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - The studies were heterogeneous in terms of intervention and biomarkers assessed, and all of them had moderate-to-high risk of bias. [Lazzarin T (2025); evidence level 1] - Overall the findings indicate positive effects of Brazil nuts and baru almond oil on oxidative stress and inflammation markers, while walnuts reduced LDL cholesterol and blood pressure while posing no risk regarding electrolytes balance. [Lazzarin T (2025); evidence level 1] - Further, the consumption of total nuts was associated with reduction in all-cause mortality. [Lazzarin T (2025); evidence level 1] - Introduction Nuts possess a beneficial nutritional profile with antioxidant and anti-inflammatory properties, potentially improving health outcomes in chronic kidney disease (CKD) patients. [Lazzarin T (2025); evidence level 1] - Previous studies have provided ample evidence that a healthy diet has an important role in delaying the development of many modifiable risk factors of CVD, including abdominal obesity, high blood pressure, abnormally high cholesterol and blood glucose levels. [Jarai Dora (2024); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.